Advertisement

Advertisement
Gynecologic Cancers

Influence of Menopausal Hormone Therapy on Gynecologic Cancer Incidence and Mortality

In 2002, the federally funded Women’s Health Initiative—a randomized, placebo-controlled clinical trial investigating the effects of menopausal hormone therapy...

Issues in Oncology

HPV Vaccine Shows Prevention Efficacy for Several Types of HPV-Related Cancers in Both Males and Females

According to the Centers for Disease Control and Prevention, since the human papillomavirus (HPV) vaccine was introduced in the United States in 2006...

Breast Cancer
Survivorship

Most Breast Cancer Survivors Able to Achieve Pregnancy After Diagnosis, Study Finds

Research examining fertility preservation and pregnancy attempts among young women following a breast cancer diagnosis has been hampered...


Advertisement
Colorectal Cancer

AI-Based Virtual Patient Navigator Boosts Colonoscopy Adherence

A novel artificial intelligence (AI)-based virtual patient navigator, MyEleanor, improved colonoscopy uptake among U.S. patients who were previously nonadherent...

Kidney Cancer
Immunotherapy

CRISPR-Edited, Off-the-Shelf CAR T-Cell Therapy Shows Proof of Concept in Renal Cell Carcinoma

Evidence from a small early trial called COBALT-RCC provides proof of concept for use of an allogeneic off-the-shelf CD70-targeted CAR T-cell therapy called CTX130...

Advertisement
Advertisement




Sponsored Content

More Top Stories


Hematologic Malignancies

Rami S. Komrokji, MD, on Myelodysplastic Neoplasms: Classifying Risks Among Subsets of Disease

Lung Cancer

ASCO Issues Updated Guidelines for Stage IV NSCLC With and Without Driver Alterations

ASCO has issued new evidence-based updates to two living guidelines on the treatment of stage IV NSCLC with and without driver alterations.1,2 Updated Recommendations: Stage IV NSCLC With Driver Alterations The most “extensive work” in the updates occurred in the guideline on stage IV NSCLC with...

Advertisement

AI-Based Virtual Patient Navigator Boosts Colonoscopy Adherence

A novel artificial intelligence (AI)-based virtual patient navigator, MyEleanor, improved colonoscopy uptake among U.S. patients who were previously nonadherent to prior colonoscopy appointments. These findings will be presented by Moadel et al at the 2024 ASCO Annual Meeting (Abstract 100)....

Paolo Corradini, MD, on PMBCL and DLBCL: Comparing Outcomes With Axicabtagene Ciloleucel

Issues in Oncology

The Future of Cancer Care

The profound progress in cancer care since President Richard Nixon signed the National Cancer Act of 1971 into law is evidenced by the soaring number of cancer survivors since the law went into effect. In the 1970s, there were 3 million cancer survivors1; today, there are more than 18 million, and...

Hematologic Malignancies

Rosai-Dorfman Disease: Sinus Histiocytosis With Massive Lymphadenopathy

“Don’t be afraid to give up the good to go for the great.”       — John D. Rockefeller The ASCO Post is pleased to present Hematology Expert Review, an ongoing feature that quizzes readers on issues in hematology. In this installment, Syed Ali Abutalib, MD, and L. Jeffrey Medeiros, MD, explore the ...

Influence of Menopausal Hormone Therapy on Gynecologic Cancer Incidence and Mortality

In 2002, the federally funded Women’s Health Initiative—a randomized, placebo-controlled clinical trial investigating the effects of menopausal hormone therapy in healthy menopausal women—was abruptly halted when it was determined that taking estrogen and progestin hormones after menopause...

Hematologic Malignancies
Leukemia

Nigel Russell, MD, on Acute Myeloid Leukemia: New Findings on FLAG-Ida and Gemtuzumab Ozogamicin

NCCN Appoints Chair, Vice-Chair of Board of Directors

The National Comprehensive Cancer Network (NCCN®) has announced the election of Matt Kalaycio, MD, FACP, as Chair of the Board of Directors, with Christopher H. Lieu, MD, elected as Vice-Chair, succeeding Dr. Kalaycio in the position he has held since 2022. “The exemplary leadership from our Board...

Advertisement

HPV Vaccine Shows Prevention Efficacy for Several Types of HPV-Related Cancers in Both Males and Females

According to the Centers for Disease Control and Prevention, since the human papillomavirus (HPV) vaccine was introduced in the United States in 2006, HPV infections that cause most HPV-related cancers and genital warts have decreased by 88% among teenage girls and 81% among young adult women. Now, ...